Tuberculosis

CHA

Tag: Tuberculosis

Tuberculosis: Sustainable solutions for children and adolescents at risk of drug-resistant TB

They walked in single file through the narrow alleyways, winding away from their tin shack in Cape Town towards the health centre. Keitu – just 11 years old – carried her baby brother on her back since their mother was...

Read more

Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior

LONDON - A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more...

Read more

Step UP For TB: Report shows new tests and drugs for world’s deadliest infectious disease remain out of reach

MSF calls on governments and donors to step up and speed up TB testing and treatmentGeneva — As the COVID-19 pandemic threatens to derail the global response to tuberculosis (TB), Doctors Without Borders/Médecins Sans Frontières (MSF) called on governments to...

Read more

Hamari Awaaz: Addressing stigma in people living with multidrug-resistant tuberculosis in India

[3d-flip-book mode="fullscreen" id="21871"][/3d-flip-book]    

Read more

endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India

Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...

Read more

Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen

New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...

Read more

Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price

NEW YORK/GENEVA - The pharmaceutical corporation Johnson & Johnson (J&J) has announced a reduced price of US$1.50 [1] per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB...

Read more

Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”

“We spent hundreds of rupees in private health clinics to trying to cure my tuberculosis, but none of the medication worked. The treatment included daily painful injections with lots of side-effects like vomiting, fatigue, loss of appetite… and sometimes even...

Read more

World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen

Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...

Read more

COVID-19: Avoiding a ‘second tragedy’ for those with TB

As the world grapples with the coronavirus COVID-19 global pandemic, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide. People with tuberculosis (TB) are among the groups that may be particularly affected. Special attention will be needed to safeguard the continuity...

Read more

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...

Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons